NOVOTECH
LIVE

Serial Number

79221025

Owner

Novotech (Australia) Pty Ltd

Attorney

Matthew P. Hintz, Esq.

Filing Date

Jun 19, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NOVOTECH Trademark

Serial Number: 79221025 • Registration: 5629966

NOVOTECH is a trademark filed by Novotech (Australia) Pty Ltd on June 19, 2017. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Novotech (Australia) Pty Ltd (8 trademarks)

L 3 235 Pyrmont St

Entity Type: 99

Trademark Details

Filing Date

June 19, 2017

Registration Date

December 18, 2018

Published for Opposition

October 2, 2018

Goods & Services

Medical and scientific research, namely, conducting clinical trials for others; conducting and managing clinical trials in the fields of pharmaceuticals, biotechnology and other related industries; conducting clinical trials for others in the nature of scientific research; providing information about the results of clinical trials in the fields of pharmaceuticals and biotechnology; scientific research; medical research in the nature of scientific research for medical purposes; preparation of statistics reports for scientific research; preparation of biostatistics reports for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; provision of information and data relating to medical and scientific research for pharmaceuticals, biotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; quality audits, namely, quality evaluation services for the pharmaceuticals industry; preparation of reports and applications to regulators relating to aspects of clinical trials; provision of information and data to scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; technical writing of clinical report forms which are required by clinical trial drug protocols

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 24, 2025 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 24, 2025 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 16, 2025 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 25, 2025 ES75
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 25, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 25, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 25, 2024 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 18, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 17, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 23, 2019 FICS
FINAL DISPOSITION PROCESSED
Mar 23, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 18, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 18, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 2, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 2, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Sep 29, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 12, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 12, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 12, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2018 CRFA
ASSIGNED TO LIE
Aug 27, 2018 ALIE
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 21, 2018 LIMN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2018 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Jun 1, 2018 LIMG
REFUSAL PROCESSED BY IB
Dec 29, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 11, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 28, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Nov 28, 2017 MAFR
NON-FINAL ACTION WRITTEN
Nov 27, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 16, 2017 REPR